King's College London

Research portal

The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials

Research output: Contribution to journalReview article

Standard

The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia : A Meta-Review of Meta-Analyses of Randomized Controlled Trials. / Vancampfort, Davy; Solmi, Marco; Firth, Joseph; Vandenbulcke, Mathieu; Stubbs, Brendon.

In: Journal Of The American Medical Directors Association, 18.02.2020.

Research output: Contribution to journalReview article

Harvard

Vancampfort, D, Solmi, M, Firth, J, Vandenbulcke, M & Stubbs, B 2020, 'The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials', Journal Of The American Medical Directors Association. https://doi.org/10.1016/j.jamda.2020.01.010

APA

Vancampfort, D., Solmi, M., Firth, J., Vandenbulcke, M., & Stubbs, B. (2020). The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials. Journal Of The American Medical Directors Association. https://doi.org/10.1016/j.jamda.2020.01.010

Vancouver

Vancampfort D, Solmi M, Firth J, Vandenbulcke M, Stubbs B. The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials. Journal Of The American Medical Directors Association. 2020 Feb 18. https://doi.org/10.1016/j.jamda.2020.01.010

Author

Vancampfort, Davy ; Solmi, Marco ; Firth, Joseph ; Vandenbulcke, Mathieu ; Stubbs, Brendon. / The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia : A Meta-Review of Meta-Analyses of Randomized Controlled Trials. In: Journal Of The American Medical Directors Association. 2020.

Bibtex Download

@article{85c684ca6bfe4539a06dbb4783cae191,
title = "The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia: A Meta-Review of Meta-Analyses of Randomized Controlled Trials",
abstract = "OBJECTIVES: We summarized and compared meta-analyses of pharmacologic and nonpharmacologic interventions targeting physical health outcomes among people with dementia.DESIGN: This is a systematic review and meta-analysis.SETTING AND PARTICIPANTS: People with dementia, confirmed through validated assessment measures.METHODS: Major databases were searched until October 21, 2019. Effect sizes [standardized mean difference (SMD)/Hedges g or risk ratio (RR)] were compared separately.RESULTS: Of 3773 search engine hits, 4 meta-analyses were included, representing 31 meta-analyzed trials and 10,054 study participants. Although meta-analyses were generally of adequate high quality, meta-analyzed studies were less so. Nutritional supplements were the only one to show a weight-increasing effect [SMD 0.53, 95{\%} confidence interval (CI) 0.38-0.68, ie, medium effect; N = 12, n = 748]. Acetylcholinesterase inhibitors are associated with an increased risk for weight loss (RR 2.1, 95{\%} CI 1.5‒3.0; N = 9, n = 7010). For the treatment of pain, sensory stimulation has a medium effect (SMD -0.58, 95{\%} CI -0.99 to -0.17; N = 6, n = 199), whereas physical activity has a small effect (SMD -0.24, 95{\%} CI -1.06 to 0.59; N = 2, n = 75). When exploring the characteristics of the psychosocial interventions, group-based interventions demonstrated a medium (SMD -0.55, 95{\%} CI -1.02 to -0.09; N = 6, n = 157) and individual psychosocial interventions a small effect (SMD -0.27, 95{\%} CI -1.06 to 0.53; N = 2, n = 55).CONCLUSIONS AND IMPLICATIONS: Despite frequent physical comorbidities, the current evidence for pharmacologic and nonpharmacologic interventions in people with dementia to prevent and treat these conditions is still in its infancy, and larger trials targeting a wide range of physical health outcomes are urgently needed. Based on the SMDs and RRs, nutritional supplements can be recommended as an intervention to treat malnutrition. Clinicians should be careful in treating patients with acetylcholinesterase inhibitors, as it shows medium weight reducing effects. For the treatment of comorbid pain, sensory stimulation and psychosocial interventions are recommended.",
keywords = "Dementia, acetylcholinesterase inhibitors, pain, physical activity, weight",
author = "Davy Vancampfort and Marco Solmi and Joseph Firth and Mathieu Vandenbulcke and Brendon Stubbs",
note = "Copyright {\circledC} 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.",
year = "2020",
month = "2",
day = "18",
doi = "10.1016/j.jamda.2020.01.010",
language = "English",
journal = "Journal Of The American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - The Impact of Pharmacologic and Nonpharmacologic Interventions to Improve Physical Health Outcomes in People With Dementia

T2 - A Meta-Review of Meta-Analyses of Randomized Controlled Trials

AU - Vancampfort, Davy

AU - Solmi, Marco

AU - Firth, Joseph

AU - Vandenbulcke, Mathieu

AU - Stubbs, Brendon

N1 - Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

PY - 2020/2/18

Y1 - 2020/2/18

N2 - OBJECTIVES: We summarized and compared meta-analyses of pharmacologic and nonpharmacologic interventions targeting physical health outcomes among people with dementia.DESIGN: This is a systematic review and meta-analysis.SETTING AND PARTICIPANTS: People with dementia, confirmed through validated assessment measures.METHODS: Major databases were searched until October 21, 2019. Effect sizes [standardized mean difference (SMD)/Hedges g or risk ratio (RR)] were compared separately.RESULTS: Of 3773 search engine hits, 4 meta-analyses were included, representing 31 meta-analyzed trials and 10,054 study participants. Although meta-analyses were generally of adequate high quality, meta-analyzed studies were less so. Nutritional supplements were the only one to show a weight-increasing effect [SMD 0.53, 95% confidence interval (CI) 0.38-0.68, ie, medium effect; N = 12, n = 748]. Acetylcholinesterase inhibitors are associated with an increased risk for weight loss (RR 2.1, 95% CI 1.5‒3.0; N = 9, n = 7010). For the treatment of pain, sensory stimulation has a medium effect (SMD -0.58, 95% CI -0.99 to -0.17; N = 6, n = 199), whereas physical activity has a small effect (SMD -0.24, 95% CI -1.06 to 0.59; N = 2, n = 75). When exploring the characteristics of the psychosocial interventions, group-based interventions demonstrated a medium (SMD -0.55, 95% CI -1.02 to -0.09; N = 6, n = 157) and individual psychosocial interventions a small effect (SMD -0.27, 95% CI -1.06 to 0.53; N = 2, n = 55).CONCLUSIONS AND IMPLICATIONS: Despite frequent physical comorbidities, the current evidence for pharmacologic and nonpharmacologic interventions in people with dementia to prevent and treat these conditions is still in its infancy, and larger trials targeting a wide range of physical health outcomes are urgently needed. Based on the SMDs and RRs, nutritional supplements can be recommended as an intervention to treat malnutrition. Clinicians should be careful in treating patients with acetylcholinesterase inhibitors, as it shows medium weight reducing effects. For the treatment of comorbid pain, sensory stimulation and psychosocial interventions are recommended.

AB - OBJECTIVES: We summarized and compared meta-analyses of pharmacologic and nonpharmacologic interventions targeting physical health outcomes among people with dementia.DESIGN: This is a systematic review and meta-analysis.SETTING AND PARTICIPANTS: People with dementia, confirmed through validated assessment measures.METHODS: Major databases were searched until October 21, 2019. Effect sizes [standardized mean difference (SMD)/Hedges g or risk ratio (RR)] were compared separately.RESULTS: Of 3773 search engine hits, 4 meta-analyses were included, representing 31 meta-analyzed trials and 10,054 study participants. Although meta-analyses were generally of adequate high quality, meta-analyzed studies were less so. Nutritional supplements were the only one to show a weight-increasing effect [SMD 0.53, 95% confidence interval (CI) 0.38-0.68, ie, medium effect; N = 12, n = 748]. Acetylcholinesterase inhibitors are associated with an increased risk for weight loss (RR 2.1, 95% CI 1.5‒3.0; N = 9, n = 7010). For the treatment of pain, sensory stimulation has a medium effect (SMD -0.58, 95% CI -0.99 to -0.17; N = 6, n = 199), whereas physical activity has a small effect (SMD -0.24, 95% CI -1.06 to 0.59; N = 2, n = 75). When exploring the characteristics of the psychosocial interventions, group-based interventions demonstrated a medium (SMD -0.55, 95% CI -1.02 to -0.09; N = 6, n = 157) and individual psychosocial interventions a small effect (SMD -0.27, 95% CI -1.06 to 0.53; N = 2, n = 55).CONCLUSIONS AND IMPLICATIONS: Despite frequent physical comorbidities, the current evidence for pharmacologic and nonpharmacologic interventions in people with dementia to prevent and treat these conditions is still in its infancy, and larger trials targeting a wide range of physical health outcomes are urgently needed. Based on the SMDs and RRs, nutritional supplements can be recommended as an intervention to treat malnutrition. Clinicians should be careful in treating patients with acetylcholinesterase inhibitors, as it shows medium weight reducing effects. For the treatment of comorbid pain, sensory stimulation and psychosocial interventions are recommended.

KW - Dementia

KW - acetylcholinesterase inhibitors

KW - pain

KW - physical activity

KW - weight

UR - http://www.scopus.com/inward/record.url?scp=85079792945&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2020.01.010

DO - 10.1016/j.jamda.2020.01.010

M3 - Review article

C2 - 32085951

JO - Journal Of The American Medical Directors Association

JF - Journal Of The American Medical Directors Association

SN - 1525-8610

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454